Statewide Clinical Support Services Industrial Liaison Forum (SCSS ILF)

11 January 2016

PSA representatives recently attended the third ILF meeting with SCSS Executive. A summary of some of the key issues raised by the PSA on behalf of members are listed below. Further details can be found in the attached agenda and minutes from the previous ILF.


  • The PSA has raised concerns about the potential increase in workload and work flow that is likely to arise from the transfers of services from Central Adelaide Local Health Network (CALHN) to Northern Adelaide Local Health Network (NALHN). The PSA has advised that we shall continue to monitor this matter.



  • With the Flinders Medical Centre Car Park (FMC) closure PSA members had raised a number of Work Health and Safety concerns. This event and process has highlighted that SCSS have not been distributing circulars or information updates directly to their SCSS workforce. The PSA is of the view that SCSS Executive must improve direct communications with staff rather than relying on SAHLN management. Ongoing feedback from members on communication from SCSS is sought.



  • The PSA has ongoing concerns about how fatigue is being managed across the 24/7 operations. The PSA has recommended that a Register of Fatigue Management be established in response to the draft on call and recall protocols developed by SAMI Executive. Consultation is ongoing and this remains on the guide. Members are strongly encouraged to continue to report any issues arising from fatigue and poor rostering and management practices.



  • With the roll-out of new ROCHE automated analysis equipment across SA Pathology the PSA is interested in any information on any potential reductions in staff numbers associated with the new mechanisation.
  • While the SA Pathology ILF is to focus on the many changes ahead for SA Pathology services, the PSA will not accept this as the only forum for consultation with the PSA and staff regarding the Ernst and Young review. The PSA will strongly advocate for consultation at the workplace level across all sites and directorates during this process.
  • The PSA raised members' concerns about the how fatigue is being managed in various labs. Euphemistically called the “shift sandwich” - i.e. on call and recall for night shift with a following shift on the same day, is putting members, clients and general public at risk. Members are strongly encouraged to continue to report any issues arising from fatigue and poor rostering and management practices to enable the PSA to keep pressure on management to properly monitor fatigue.



  • SA Pharmacy has indicated that a Manufacturing Review (Roadmap) is expected in 2016. What this means for members remains to be seen. The PSA will continue to report any new information if and when it is received.
  • Members at The Queen Elizabeth Hospital have had a number of issues to contend with including the ongoing funding of clinical trials; a potential move from a seven day to a five day roster; trends in increasing pharmacist overtime; unexplained changes to contracts of employment. The PSA has and will continue to watch and advocate for members and will keep members informed of any new information.
  • The PSA requested an update on the promised consultation paper about In-Pharmacy Robotics and Automated Dispensing Cabinets at the nRAH. SA Pharmacy had committed to provide the PSA with any potential staffing impacts – e.g. any reduction in staff numbers; changes to staff 'mix'; training needs and changes to work-flow.


The minutes from the last ILF are attached here.

Members who have an interest in attending the next or any future ILF should contact the PSA.